Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 12-2019 | 06-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,934 | 200 | 572 | 5,304 | 64 |
| Receivables | 3,135 | 1,140 | 1,378 | 1,042 | 0 |
| Other current assets | 0 | 165 | 0 | 567 | 2,384 |
| TOTAL | $12,069 | $1,505 | $1,950 | $6,913 | $2,448 |
| Non-Current Assets | |||||
| PPE Net | 53 | 6 | 48 | 46 | 46 |
| Other Non-Current Assets | 562 | 434 | 739 | 0 | 0 |
| TOTAL | $615 | $440 | $787 | $46 | $46 |
| Total Assets | $13,020 | $2,378 | $2,696 | $6,920 | $2,471 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,704 | 6,396 | 6,078 | 6,401 | 4,740 |
| Other current liabilities | 401 | 676 | N/A | 0 | 0 |
| TOTAL | $6,505 | $7,351 | $6,189 | $6,401 | $4,749 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $356 | $N/A | $N/A |
| Total Liabilities | $6,887 | $7,892 | $6,545 | $6,401 | $4,749 |
| Shareholders' Equity | |||||
| Common Shares | 6,195 | 8,599 | 5,264 | 8,592 | 8,140 |
| Retained earnings | -58,732 | -60,044 | -50,725 | -50,721 | -42,613 |
| Other shareholders' equity | 11,032 | 6,000 | 8,318 | 1,786 | 915 |
| TOTAL | $6,133 | $-5,514 | $-3,849 | $519 | $-2,278 |
| Total Liabilities And Equity | $13,020 | $2,378 | $2,696 | $6,920 | $2,471 |